Dian Diagnostics GroupLtd Future Growth
Future criteria checks 3/6
Dian Diagnostics GroupLtd is forecast to grow earnings and revenue by 43% and 9.6% per annum respectively. EPS is expected to grow by 43% per annum. Return on equity is forecast to be 9.3% in 3 years.
Key information
43.0%
Earnings growth rate
43.0%
EPS growth rate
Healthcare earnings growth | 21.4% |
Revenue growth rate | 9.6% |
Future return on equity | 9.3% |
Analyst coverage | Good |
Last updated | 25 Jul 2024 |
Recent future growth updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For Dian Diagnostics GroupLtd (SZSE:300244)
Jul 12Dian Diagnostics GroupLtd (SZSE:300244) Will Pay A Smaller Dividend Than Last Year
Jun 10Dian Diagnostics GroupLtd (SZSE:300244) Seems To Use Debt Quite Sensibly
May 24Dian Diagnostics Group Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Apr 30Investors Holding Back On Dian Diagnostics Group Co.,Ltd. (SZSE:300244)
Apr 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 17,083 | 988 | 1,155 | 2,094 | 10 |
12/31/2025 | 15,734 | 814 | 720 | 1,460 | 11 |
12/31/2024 | 14,179 | 637 | 156 | 1,886 | 10 |
3/31/2024 | 13,150 | 170 | 1,263 | 1,883 | N/A |
12/31/2023 | 13,408 | 307 | 1,220 | 1,921 | N/A |
9/30/2023 | 14,945 | -463 | 1,065 | 1,954 | N/A |
6/30/2023 | 16,371 | 8 | 1,376 | 2,239 | N/A |
3/31/2023 | 18,865 | 841 | 1,444 | 2,384 | N/A |
1/1/2023 | 20,282 | 1,434 | 692 | 1,639 | N/A |
9/30/2022 | 19,374 | 2,358 | 173 | 897 | N/A |
6/30/2022 | 18,045 | 2,316 | -124 | 627 | N/A |
3/31/2022 | 14,863 | 1,578 | 102 | 756 | N/A |
1/1/2022 | 13,083 | 1,163 | 728 | 1,318 | N/A |
9/30/2021 | 12,515 | 1,136 | 1,050 | 1,591 | N/A |
6/30/2021 | 11,967 | 1,029 | 1,115 | 1,646 | N/A |
3/31/2021 | 11,985 | 1,135 | 946 | 1,456 | N/A |
12/31/2020 | 10,649 | 803 | 1,072 | 1,547 | N/A |
9/30/2020 | 9,716 | 895 | 407 | 780 | N/A |
6/30/2020 | 8,932 | 601 | 221 | 552 | N/A |
3/31/2020 | 8,150 | 281 | 99 | 409 | N/A |
12/31/2019 | 8,453 | 347 | 72 | 483 | N/A |
9/30/2019 | 8,291 | 448 | 164 | 602 | N/A |
6/30/2019 | 8,006 | 433 | -2 | 471 | N/A |
3/31/2019 | 7,593 | 398 | -97 | 423 | N/A |
12/31/2018 | 6,967 | 389 | -83 | 373 | N/A |
9/30/2018 | 6,214 | 392 | -299 | 140 | N/A |
6/30/2018 | 5,640 | 373 | -427 | 31 | N/A |
3/31/2018 | 5,169 | 356 | -463 | -49 | N/A |
12/31/2017 | 5,004 | 350 | N/A | 39 | N/A |
9/30/2017 | 4,903 | 325 | N/A | -79 | N/A |
6/30/2017 | 4,515 | 308 | N/A | -46 | N/A |
3/31/2017 | 4,233 | 279 | N/A | 21 | N/A |
12/31/2016 | 3,824 | 263 | N/A | 132 | N/A |
9/30/2016 | 3,147 | 238 | N/A | 67 | N/A |
6/30/2016 | 2,673 | 221 | N/A | 93 | N/A |
3/31/2016 | 2,165 | 188 | N/A | 84 | N/A |
12/31/2015 | 1,858 | 175 | N/A | 131 | N/A |
9/30/2015 | 1,645 | 161 | N/A | 137 | N/A |
6/30/2015 | 1,523 | 151 | N/A | 160 | N/A |
3/31/2015 | 1,411 | 132 | N/A | 85 | N/A |
12/31/2014 | 1,335 | 125 | N/A | 118 | N/A |
9/30/2014 | 1,275 | 113 | N/A | 123 | N/A |
6/30/2014 | 1,178 | 103 | N/A | 121 | N/A |
3/31/2014 | 1,082 | 90 | N/A | 97 | N/A |
12/31/2013 | 1,015 | 86 | N/A | 75 | N/A |
9/30/2013 | 936 | 80 | N/A | 65 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300244's forecast earnings growth (43% per year) is above the savings rate (2.9%).
Earnings vs Market: 300244's earnings (43% per year) are forecast to grow faster than the CN market (22.1% per year).
High Growth Earnings: 300244's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300244's revenue (9.6% per year) is forecast to grow slower than the CN market (13.6% per year).
High Growth Revenue: 300244's revenue (9.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300244's Return on Equity is forecast to be low in 3 years time (9.3%).